Estudo de nanocompósitos luminescentes baseados em complexos de Eu(III) e Ir(III) ancorados à nanopartículas de sílica por bases de Schiff

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Entrapment characteristics of hydrosoluble vitamins loaded into chitosan and N,N,N-trimethyl chitosan nanoparticles

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Nanocompósitos multifuncionas de fibroína reforçados com biocelulose

This work shows the preparation and characterization of the new nanocomposites based on fibroin and biocellulose. Bacterial cellulose (BC) is an exopolysaccharide produced by bacteria of the genus Gluconacetobacter, which it has identical chemical structure of the cellulose from plants and it has gained attention in the field of research for its unique properties as excellent mechanical properties when dry and hydrated , higher capacity of water retention, moldability , biodegradability and excellent biological affinity . Silk fibroin (SF) is a structural protein present in the cocoon of the silkworm, Bombyx mori, has been identified as suitable for developing optical devices, tissue engineering application, enzyme immobilization, controlled release drug agent biopolymer. Silk fibroin/bacterial cellulose nanocomposite films were prepared impregnating different cellulose charges (0.5 %, 1.0 %, 1.5 %, 2.5 %, 5.0 % and 10.0 %) weight/weight. According mechanical tests and water and Paynes's cup permeability showed that SF/BC 1% nanocomposite has the most relevant results. Poliethylenoglicol (PEG) containing SF films improved optical and mechanical properties when compared to pristine SF film. New SF/BC nanocomposites could be applied in Medicine, as biodegradable packaging and flexible substrates for OLEDs.

Sistemas precursores de cristais líquidos mucoadesivos para administração bucal de curcumina no tratamento do câncer bucal

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Development and characterization of cefoxitin loaded D,L-PLA nanoparticles

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Surfactant-based transdermal system for fluconazole skin delivery

Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)

Síntese e caracterização de matrizes híbridas para aplicação em sistemas de liberação controlada

Pós-graduação em Ciência dos Materiais - FEIS

Estudo da incorporação e liberação de peptídeos hormonais utilizando membranas de látex natural como carreador

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Síntese e caracterização de hidrogéis nanoestruturados contendo nanoargila e zeólita com potencialidade de aplicação em sistemas de liberação controlada de fármacos

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Síntese, caracterização e aplicação de hidrogéis nanoestruturados contendo nanoargila para melhorar a germinação e qualidade de muda de hortaliça

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)

Síntese e caracterização de nanocompósitos constituídos por nanoargila e hidrogel para uso agrícola

Pós-graduação em Ciência dos Materiais - FEIS

Produtividade e qualidade de grãos da cultura do feijão em função do uso de fertilizante nitrogenado de liberação lenta via foliar

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Produtividade e qualidade de grãos da cultura do feijão em função do uso de fertilizante nitrogenado de liberação lenta via foliar

Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)

Antioxidant Effects of Quercetin and Catechin Encapsulated into PLGA Nanoparticles

Polymeric nanoparticles (PLGA) have been developed for the encapsulation and controlled release of quercetin and catechin. Nanoparticles were fabricated using a solvent displacementmethod. Physicochemical properties were measured by light scattering, scanning electron microscopy and zeta-potential, X-ray diffraction, infrared spectroscopy and differential scanning calorimetry. Encapsulation efficiency and in vitro release profiles were obtained from differential pulse voltammetry experiments. Antioxidant properties of free and encapsulated flavonoids were determined by TBARS, fluorescence spectroscopy and standard chelating activity methods. Relatively small (d approximate to 400 nm) polymeric nanoparticles were obtained containing quercetin or catechin in a non-crystalline form (EE approximate to 79%) and the main interactions between the polymer and each flavonoid were found to consist of hydrogen bonds. In vitro release profiles were pH-dependant, the more acidic pH, the faster release of each flavonoid from the polymeric nanoparticles. The inhibition of the action of free radicals and chelating properties, were also enhanced when quercetin and catechin were encapsulated within PLGA nanoparticles. The information obtained from this study will facilitate the design and fabrication of polymeric nanoparticles as possible oral delivery systems for encapsulation, protection and controlled release of flavonoids aimed to prevent oxidative stress in human body or food products.

Exogenous Administration of 15d-PGJ(2)-Loaded Nanocapsules Inhibits Bone Resorption in a Mouse Periodontitis Model

The 15-deoxy-(Delta 12,14)-PG J(2) (15d-PGJ(2)) has demonstrated excellent anti-inflammatory results in different experimental models. It can be used with a polymeric nanostructure system for modified drug release, which can change the therapeutic properties of the active principle, leading to increased stability and slower/prolonged release. The aim of the current study was to test a nano-technological formulation as a carrier for 15d-PGJ(2), and to investigate the immunomodulatory effects of this formulation in a mouse periodontitis model. Poly (D, L-lactide-coglycolide) nanocapsules (NC) were used to encapsulate 15d-PGJ(2). BALB/c mice were infected on days 0, 2, and 4 with Aggregatibacter actinomycetemcomitans and divided into groups (n = 5) that were treated daily during 15 d with 1, 3, or 10 mu g/kg 15d-PGJ(2)-NC. The animals were sacrificed, the submandibular lymph nodes were removed for FACS analysis, and the jaws were analyzed for bone resorption by morphometry. Immunoinflammatory markers in the gingival tissue were analyzed by reverse transcriptase-quantitative PCR, Western blotting, or ELISA. Infected animals treated with the 15d-PGJ(2)-NC presented lower bone resorption than infected animals without treatment (p < 0.05). Furthermore, infected animals treated with 10 mu g/kg 15d-PGJ(2)-NC had a reduction of CD4(+)CD25(+)FOXP3(+) cells and CD4/CD8 ratio in the submandibular lymph node (p < 0.05). Moreover, CD55 was upregulated, whereas RANKL was downregulated in the gingival tissue of the 10 mu g/kg treated group (p < 0.05). Several proinflammatory cytokines were decreased in the group treated with 10 mu g/kg 15d-PGJ(2)-NC, and high amounts of 15d-PGJ(2) were observed in the gingiva. In conclusion, the 15d-PGJ(2)-NC formulation presented immunomodulatory effects, decreasing bone resorption and inflammatory responses in a periodontitis mouse model. The Journal of Immunology, 2012, 189: 1043-1052.